{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:35:26Z","timestamp":1769171726493,"version":"3.49.0"},"reference-count":11,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":560,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"VR Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1111\/dth.12121","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T18:02:21Z","timestamp":1392746541000},"page":"219-222","source":"Crossref","is-referenced-by-count":6,"title":["Acridone acetic acid, sodium salt, as an agent to stop vitiligo progression: a pilot study"],"prefix":"10.1155","volume":"27","author":[{"given":"Igor V.","family":"Korobko","sequence":"first","affiliation":[{"name":"VR Foundation; New York New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin M.","family":"Lomonosov","sequence":"additional","affiliation":[{"name":"Department of Skin and Venereal Diseases; I.M. Sechenov First Moscow State Medical University; Moscow Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"key":"10.1111\/dth.12121-BIB0001|dth12121-cit-0001","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1111\/dth.12121-BIB0002|dth12121-cit-0002","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12121-BIB0003|dth12121-cit-0003","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.autrev.2011.02.004","article-title":"Immunopathogenesis of vitiligo","volume":"10","author":"Sandoval-Cruz","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1111\/dth.12121-BIB0004|dth12121-cit-0004","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-148X.2011.00920.x","article-title":"Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo","volume":"25","author":"Ben Ahmed","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/dth.12121-BIB0005|dth12121-cit-0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1755-148X.2010.00688.x","article-title":"Reduced skin homing by functional Treg in vitiligo","volume":"23","author":"Klarquist","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/dth.12121-BIB0006|dth12121-cit-0006","doi-asserted-by":"crossref","first-page":"e37513","DOI":"10.1371\/journal.pone.0037513","article-title":"Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo","volume":"7","author":"Lili","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/dth.12121-BIB0007|dth12121-cit-0007","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1755-148X.2012.01019.x","article-title":"Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T cells","volume":"25","author":"Zhou","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/dth.12121-BIB0008|dth12121-cit-0008","first-page":"14","article-title":"Immunotherapy of lupus erythematosus","volume":"2","author":"Glavinskaya","year":"2006","journal-title":"Russ J Skin Vener Dis"},{"key":"10.1111\/dth.12121-BIB0009|dth12121-cit-0009","first-page":"23","article-title":"Experience of cycloferon use in treatment of psoriasis","volume":"2","author":"Ershov","year":"1999","journal-title":"Vestn Dermatol Venerol"},{"issue":"Suppl. 1","key":"10.1111\/dth.12121-BIB0010|dth12121-cit-0010","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/dth.12008","article-title":"Review of current clinical studies of vitiligo treatments","volume":"25","author":"Korobko","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1111\/dth.12121-BIB0011|dth12121-cit-0011","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1468-3083.2007.01980.x","article-title":"Narrowband UVB therapy for vitiligo: does the repigmentation last?","volume":"21","author":"Sitek","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12121","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12121\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:54:39Z","timestamp":1671818079000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12121"}},"subtitle":["Sodium acridone acetate in vitiligo treatment"],"short-title":[],"issued":{"date-parts":[[2014,2,18]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12121","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,18]]}}}